Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Winston

Showing results (131-140 of 241) with videos related to

Pageof 25
Sort By:
Plos One|August 1, 2014
Neurocognitive function in HIV-infected patients: comparison of two methods to define impairmentAlejandro Arenas-Pinto, Alan Winston, Wolfgang Stöhr, et al.
Plos One|February 28, 2015
Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cARTAlan Winston, Rebekah Puls, Stephen J Kerr, et al.
Scientific Reports|November 1, 2019
Responses to Quadrivalent Influenza Vaccine Reveal Distinct Circulating CD4+CXCR5+ T Cell Subsets in Men Living with HIVMegan E Cole, Zainab Saeed, A Torm Shaw, et al.
British Journal of Clinical Pharmacology|March 6, 2019
Cerebrospinal fluid exposure of cenicriviroc in HIV-positive individuals with cognitive impairmentJasmini Alagaratnam, Sujan Dilly-Penchala, Elizabeth Challenger, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2011
CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite studyLucy Garvey, Mark Nelson, Ngaire Latch, et al.
Journal of Multimorbidity and Comorbidity|April 7, 2025
Multimorbidity frameworks impact the composition of patterns and their associations with patient-reported outcomes among people with HIVLuxsena Sukumaran, Alan Winston, Jane Anderson, et al.
AIDS (London, England)|February 14, 2018
Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individualsBorja Mora-Peris, George Bouliotis, Kulasegaram Ranjababu, et al.
HIV Research & Clinical Practice|November 8, 2021
Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trialBorja Mora-Peris, Michael R Keegan, Sujan Dilly Penchala, et al.
AIDS (London, England)|June 6, 2025
Changes in multimorbidity burden and their impact on patient and healthcare outcomes in people with HIV over a 3-5-year periodLuxsena Sukumaran, Alan Winston, Frank A Post, et al.
Neuroradiology|July 10, 2012
Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapyAlan Winston, Chris Duncombe, Patrick C K Li, et al.
Pageof 25

Showing results (131-140 of 241) with videos related to

Sort By:
Pageof 25
Plos One|August 1, 2014
Neurocognitive function in HIV-infected patients: comparison of two methods to define impairmentAlejandro Arenas-Pinto, Alan Winston, Wolfgang Stöhr, et al.
Plos One|February 28, 2015
Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cARTAlan Winston, Rebekah Puls, Stephen J Kerr, et al.
Scientific Reports|November 1, 2019
Responses to Quadrivalent Influenza Vaccine Reveal Distinct Circulating CD4+CXCR5+ T Cell Subsets in Men Living with HIVMegan E Cole, Zainab Saeed, A Torm Shaw, et al.
British Journal of Clinical Pharmacology|March 6, 2019
Cerebrospinal fluid exposure of cenicriviroc in HIV-positive individuals with cognitive impairmentJasmini Alagaratnam, Sujan Dilly-Penchala, Elizabeth Challenger, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2011
CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite studyLucy Garvey, Mark Nelson, Ngaire Latch, et al.
Journal of Multimorbidity and Comorbidity|April 7, 2025
Multimorbidity frameworks impact the composition of patterns and their associations with patient-reported outcomes among people with HIVLuxsena Sukumaran, Alan Winston, Jane Anderson, et al.
AIDS (London, England)|February 14, 2018
Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individualsBorja Mora-Peris, George Bouliotis, Kulasegaram Ranjababu, et al.
HIV Research & Clinical Practice|November 8, 2021
Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trialBorja Mora-Peris, Michael R Keegan, Sujan Dilly Penchala, et al.
AIDS (London, England)|June 6, 2025
Changes in multimorbidity burden and their impact on patient and healthcare outcomes in people with HIV over a 3-5-year periodLuxsena Sukumaran, Alan Winston, Frank A Post, et al.
Neuroradiology|July 10, 2012
Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapyAlan Winston, Chris Duncombe, Patrick C K Li, et al.
Pageof 25